The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in ...
The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no ...
September 26, 2006 — The US Food and Drug Administration (FDA) and Genentech, Inc, have notified healthcare professionals regarding safety labeling revisions for bevacizumab injection (Avastin) that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback